Waggoner Jesse J, Balmaseda Angel, Gresh Lionel, Sahoo Malaya K, Montoya Magelda, Wang Chunling, Abeynayake Janaki, Kuan Guillermina, Pinsky Benjamin A, Harris Eva
Division of Infectious Diseases and Geographic Medicine, Department of Medicine.
National Virology Laboratory, Centro Nacional de Diagnóstico y Referencia.
J Infect Dis. 2016 Oct 1;214(7):986-93. doi: 10.1093/infdis/jiw099. Epub 2016 Mar 16.
Infection with any of the 4 related dengue virus serotypes (DENV-1-4) is thought to result in lifelong immunity to homotypic reinfection (ie, reinfection with the same serotype).
Archived serum samples collected as part of an ongoing pediatric dengue cohort study in Nicaragua were tested for DENV by real-time reverse transcription polymerase chain reaction. Samples were collected from 2892 children who presented with an acute febrile illness clinically attributed to a non-DENV cause (hereafter, "C cases"). Test results were added to a database of previously identified symptomatic dengue cases in the cohort to identify repeat infections.
Four patients with homotypic DENV reinfections were identified and confirmed among 29 repeat DENV infections (13.8%) with serotype confirmation. Homotypic reinfections with DENV-1, DENV-2, and DENV-3 occurred 325-621 days after the initial infection. Each patient experienced 1 symptomatic dengue case and 1 DENV-positive C case, and 2 patients presented with symptomatic dengue during their second infection. These DENV-positive C cases did not elicit long-lived humoral immune responses, despite viremia levels of up to 6.44 log10 copies per mL of serum.
We describe the first set of virologically confirmed homotypic DENV reinfections. Such cases challenge the current understanding of DENV immunity and have important implications for modeling DENV transmission.
感染4种相关登革病毒血清型(DENV-1 - 4)中的任何一种被认为可产生对同型再感染(即再次感染相同血清型)的终身免疫力。
作为尼加拉瓜一项正在进行的儿科登革热队列研究的一部分收集的存档血清样本,通过实时逆转录聚合酶链反应检测登革病毒。样本采集自2892名临床表现为急性发热性疾病且临床归因于非登革病毒病因的儿童(以下简称“C组病例”)。检测结果被添加到该队列中先前确定的有症状登革热病例数据库,以识别重复感染。
在29例经血清型确认的登革病毒重复感染病例(13.8%)中,鉴定并确认了4例同型登革病毒再感染患者。DENV-1、DENV-2和DENV-3的同型再感染发生在初次感染后325 - 621天。每位患者经历1例有症状的登革热病例和1例登革病毒阳性的C组病例,2例患者在第二次感染期间出现有症状的登革热。这些登革病毒阳性的C组病例尽管血清病毒血症水平高达每毫升6.44 log10拷贝,但并未引发持久的体液免疫反应。
我们描述了第一组经病毒学确认的同型登革病毒再感染病例。此类病例挑战了当前对登革病毒免疫的认识,并对登革病毒传播模型具有重要意义。